Soluble urokinase plasminogen activator receptor levels predict survival in patients with portal hypertension undergoing TIPS

Soluble urokinase plasminogen activator receptor levels predict survival in patients with portal hypertension undergoing TIPS

Background & Aims: Transjugular intrahepatic portosystemic shunt (TIPS) is the most effective therapy for complications of portal hypertension. However, clinical outcomes following TIPS placement vary widely between patients and identifying ideal candidates remains a challenge. Soluble uroki...

Full description

Bibliographic Details
Main Authors: Sven H. Loosen, Fabian Benz, Raphael Mohr, Philipp A. Reuken, Theresa H. Wirtz, Lioba Junker, Christian Jansen, Carsten Meyer, Michael Praktiknjo, Alexander Wree, Johanna Reißing, Münevver Demir, Wenyi Gu, Mihael Vucur, Robert Schierwagen, Andreas Stallmach, Anselm Kunstein, Johannes Bode, Christian Trautwein, Frank Tacke, Tom Luedde, Tony Bruns, Jonel Trebicka, Christoph Roderburg
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:JHEP Reports
Subjects:
suPAR
TIPS
portal hypertension
survival
biomarker
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555924000557

Internet

http://www.sciencedirect.com/science/article/pii/S2589555924000557

Similar Items